high, subsiding as the disease moves to a more chronic phase 3 . These cytokines are probably the cause of the abnormal capillary permeability and oedema. Tubular proteinuria, which was present in our patient, has been reported in association with high levels of circulating cytokines in other inflammatory diseases 4 . Oedema, either localized or generalized, is commonly seen in the rheumatic diseases and presumably likewise results from a cytokineinduced vascular leak. In dermatomyositis the oedema may be localized around the eyes or may be generalized, with substantial weight gain 5 . In rheumatoid arthritis, localized limb oedema is a well-known phenomenon; it has also been reported in systemic lupus erythematosus 5 and diffuse systemic scleroderma 6 . In many cases it responds well to treatment with steroids. Widespread systemic vascular leakage is seen in patients treated with interleukin 2, interferon a and immunotoxins, and commonly it is the dose-limiting factor in these treatments 7 . Spontaneous 'systemic capillary leak syndrome' is very rare and tends to be associated with monoclonal gammopathy, which was excluded in our patient; in this syndrome there is episodic severe hypotension and haemoconcentration as well as profound hypoalbuminaemia 1 . The primary cause seems to be a circulating toxic factor that increases capillary permeability, perhaps by causing endothelial cell apoptosis 8 .
The treatment of scleroderma is made difficult by the variability of its natural course and uncertainty as to its pathogenesis 9 . Immunosuppressant agents such as methotrexate have been used, with encouraging results in one small trial 10 . Because our patient's symptoms developed while she was taking methotrexate, she was treated initially with the antifibrotic agent penicillamine. Spontaneous improvement of scleroderma/morphea is well recognized, so we cannot be sure that the course of her illness was affected by the treatment. Splenic artery aneurysms occur in approximately 1% of the population and are usually incidental findings 1 . Rupture carries a substantial mortality 2 .
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CASE HISTORY
A woman of 76 with a history of hypertension, pulmonary embolus and rectal adenocarcinoma was found to have a splenic artery aneurysm (SAA) of 3-4 cm on routine surveillance ultrasound scan of the liver. She had never been pregnant. At no point did she have any symptoms or signs of the aneurysm, such as abdominal pain or an abdominal mass. Initial contrast runs of the coeliac axis showed a 4 cm aneurysm at the splenic hilum and also a 1.5 cm aneurysm of the left hepatic artery (Figure 1 ). The splenic artery aneurysm was not suitable for embolization because its position close to the splenic hilum allowed for little collateral blood supply and post-embolization infarction of the spleen was likely. The hepatic artery aneurysm was successfully embolized with thrombogenic steel coils. The following day, after immunization against Streptococcus pneumoniae and Haemophilus influenzae type b, she underwent splenectomy and removal of the SAA. Sixteen months postoperatively she was in good health.
COMMENT
The incidence of SAA is quoted as being 0.7% of the population but necropsy studies have given rates as high as Incidental diagnosis of SAA is becoming increasingly frequent with the growing use of angiograms, CT scans and ultrasonograms for investigation of other lesions 2 . The peak age of detection is the sixth decade 1 . The cause of these aneurysms is uncertain, but increased blood flow through the splenic artery may be a factor. Portal hypertension with large portasystemic shunts causes a rise in portal blood inflow volume which is thought to increase the aneurysmal propensity of the splenic artery ,1,2,5 . Arteriosclerosis is the commonest pathological finding and is probably a postaneurysmal phenomenon rather than a primary cause of the aneurysm. Half the ruptures occur in pregnant women and the mortality after rupture is 70-90% 6 .
For patients aged over 60 years with no symptoms and with aneurysms less than 20 mm in diameter, conservative management with CT scans every six to twelve months is advocated 4 . Treatment is indicated for aneurysms that cause symptoms, those more than 30 mm in diameter, and those detected in women who are pregnant or of childbearing age: these are groups with an increased risk of rupture 2,3 . There is no clear advice on how to manage aneurysms between 20 and 30 mm.
The favoured method of treatment at present is embolization. However, there is little follow-up information for this method and recurrence is a possible long-term hazard 3 . When embolization is difficult or contraindicated by the proximity of the aneurysm to the spleen (with risk of splenic infarction) the options are open or laparoscopic surgery with ligation of the splenic artery, excision of the aneurysm with reanastomosis of the artery or splenectomy with removal of the aneurysm 3 . Hyponatraemia is commonly attributed to the syndrome of inappropriate antidiuretic hormone secretion (SIADH), but other causes must first be excluded.
CASE HISTORY
A man of 66 attended the emergency department because of confusion, unsteadiness, slurred speech, nausea and symptoms of prostatic obstruction. For the past month he had been troubled by fatigue and myalgia, and for ten days he had been experiencing nausea (treated by his general practitioner with prochlorperazine). Previously he had been well, and prochlorperazine was his only current medication. On examination he was not obviously dehydrated. Blood pressure was 120/80 mm Hg, with no postural drop. There were no focal neurological signs and no physical abnormalities were detected elsewhere, including the prostate. Initial investigation disclosed pronounced hyponatraemia (sodium 110 mmol/L), low serum osmolality (261 mosm/kg) and inappropriately high urine osmolality (462 mosm/kg). Other blood results, including prostate specific antigen, 
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